Preoperative Portal Vein Embolization for Extended Hepatectomy

ObjectiveTo examine the authors’ experience with preoperative ipsilateral portal vein embolization (PVE) and assess its role in extended hepatectomy. Summary Background DataExtended hepatectomy (five or more liver segments) has been associated with higher complication rates and increased postoperative liver dysfunction than have standard hepatic resections involving lesser volumes. Recently, PVE has been used in patients who have a predicted (postresection) future liver remnant (FLR) volume less than 25% of total liver volume in an attempt to increase the FLR and reduce complications. MethodsSixty patients from 1996 to 2002 were reviewed. Thirty-nine patients had PVE preoperatively. Eight patients who had PVE were not resected either due to the discovery of additional unresectable disease after embolization but before surgery (n = 5) or due to unresectable disease at surgery (n = 3). Therefore, 31 patients who had PVE subsequently underwent extended hepatic lobectomy. A comparable cohort of 21 patients who had an extended hepatectomy without PVE were selected on the basis of demographic, tumor, and liver volume characteristics. Patients had colorectal liver metastases (n = 30), hepatocellular carcinoma (n = 15), Klatskin tumors (n = 9), peripheral cholangiocarcinoma (n = 3), and other tumors (n = 3). The 52 resections performed included 42 extended right hepatectomies, 6 extended left hepatectomies, and 4 right hepatectomies extended to include the middle hepatic vein and the caudate lobe but preserving the majority of segment 4. Concomitant vascular reconstruction of either the inferior vena cava or hepatic veins was performed in five patients. ResultsThere were no differences between PVE and non-PVE groups in terms of tumor number, tumor size, tumor type, surgical margin status, complexity of operation, or perioperative red cell transfusion requirements. The predicted FLR was similar between PVE and non-PVE groups at presentation. After PVE the FLR was higher than in the non-PVE group. No complications were observed after PVE before resection. There was no difference in postoperative mortality, with one death from liver failure in the non-PVE group and no operative mortality in the PVE group. Postoperative peak bilirubin was higher in the non-PVE than the PVE group, as were postoperative fresh-frozen plasma requirements. Liver failure (defined as the development of encephalopathy, ascites requiring sustained diuretics or paracentesis, or coagulopathy unresponsive to vitamin K requiring fresh-frozen plasma after the first 24 hours postresection) was higher in the non-PVE patients than the PVE patients. The hospital stay was longer in the non-PVE than the PVE group. ConclusionsPreoperative PVE is a safe and effective method of increasing the remnant liver volume before extended hepatectomy. Increasing the remnant liver volume in patients with estimated postresection volumes of less than 25% appears to reduce postoperative liver dysfunction.

[1]  E. Abdalla,et al.  Portal vein embolization: rationale, technique and future prospects , 2001, The British journal of surgery.

[2]  T. Muto,et al.  Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization , 2001, Hepatology.

[3]  Roland Materne,et al.  Body surface area and body weight predict total liver volume in Western adults , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  M. Makuuchi,et al.  Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. , 1990, Surgery.

[5]  H. Maeta,et al.  Is preoperative portal vein embolization effective in improving prognosis after major hepatic resection in patients with advanced‐stage hepatocellular carcinoma? , 2001, Cancer.

[6]  R. Howard,et al.  Resection of the Inferior Vena Cava for Hepatic Malignancy , 2001, The American surgeon.

[7]  H. Bismuth,et al.  Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. , 2000, Annals of surgery.

[8]  Yuman Fong,et al.  Improvement in Perioperative Outcome After Hepatic Resection: Analysis of 1,803 Consecutive Cases Over the Past Decade , 2002, Annals of surgery.

[9]  R. Howard,et al.  Hepatic Vein Reconstruction for Resection of Hepatic Tumors , 2002, Annals of surgery.

[10]  D. Vera,et al.  In vitro quantification of asialoglycoprotein receptor density from human hepatic microsamples. , 1994, Methods in enzymology.

[11]  T. Utsunomiya,et al.  Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. , 1999, Journal of the American College of Surgeons.

[12]  K. Ahrar,et al.  Transhepatic portal vein embolization: anatomy, indications, and technical considerations. , 2002, Radiographics : a review publication of the Radiological Society of North America, Inc.

[13]  M. Brennan,et al.  Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. , 1998, Surgery.

[14]  O. Farges,et al.  Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. , 2000, Journal of the American College of Surgeons.

[15]  H. Bismuth,et al.  Percutaneous Portal Vein Embolization Increases the Feasibility and Safety of Major Liver Resection for Hepatocellular Carcinoma in Injured Liver , 2000, Annals of surgery.

[16]  A. Hemming,et al.  Ex vivo liver resection with replacement of the inferior vena cava and hepatic vein replacement by transposition of the portal vein. , 1999, Journal of the American College of Surgeons.

[17]  M. Makuuchi,et al.  The Brisbane 2000 terminology of liver anatomy and resections. , 2000 .

[18]  Steven A Curley,et al.  Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. , 2002, Archives of surgery.

[19]  J. Melendez,et al.  Extended hepatic resection: a 6-year retrospective study of risk factors for perioperative mortality. , 2001, Journal of the American College of Surgeons.

[20]  M. Kudo,et al.  Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin , 1993, Hepatology.

[21]  B. Nordlinger,et al.  Dormant liver metastases: an experimental study , 1992, The British journal of surgery.

[22]  H. Kinoshita,et al.  Preoperative portal vein embolization for hepatocellular carcinoma , 1986, World Journal of Surgery.

[23]  L H Blumgart,et al.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.

[24]  K. Do,et al.  Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. , 2000, Surgery.

[25]  H Imamura,et al.  Small-for-size grafts in living-related liver transplantation. , 2001, Journal of the American College of Surgeons.

[26]  H. Tsuboi,et al.  Estimation of remnant liver function before hepatectomy by means of technetium-99m-diethylenetriamine-pentaacetic acid galactosyl human albumin , 2004, Cancer Chemotherapy and Pharmacology.

[27]  T. de Baère,et al.  During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma , 1999, The British journal of surgery.

[28]  H. Kinoshita,et al.  Evaluation of the effect of portal vein embolization on liver function by (99m)tc-galactosyl human serum albumin scintigraphy. , 2002, The Journal of surgical research.